Global Market Study on Pancreatic and Biliary Stents: Wide Availability of Advanced, Self-expandable, & Fully Covered Stents Assisting Growth


Pancreatic And Biliary Stents  Market
  • Published On : May-2019 |
  • Pages : 245 Pages |
  • Format :

PMR’s recent market study titled “Pancreatic and Biliary Stents Market: Global Industry Analysis 2014 - 2018 and Forecast 2019 - 2029” comprises a comprehensive assessment of the key market dynamics. Upon conducting detailed research on the historic as well as current growth parameters of the pancreatic and biliary stent market, the growth prospects of the pancreatic and biliary stent market have been obtained with maximum precision.

The report features the unique and salient factors that are likely to have a significant impact on the development of the pancreatic and biliary stent market during the forecast period. These factors can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the pancreatic and biliary stent market in the coming years. The report provides detailed information about the current and future growth prospects of the pancreatic and biliary stent market in the most comprehensive manner, for the better understanding of readers. The wearable devices segment in one of the most promising revenue-generating segments in the pancreatic and biliary stent market.

The report commences with the executive summary of the pancreatic and biliary stent market, which includes a summary of the key findings and statistics. It also includes the market value (US$ million) estimates of the prominent segments of the pancreatic and biliary stent market. Readers can find detailed taxonomy and definitions pertaining to the pancreatic and biliary stent market in this chapter, which will help them understand the basic information about the market dynamics, company share, cost structure, pricing analysis, a list of key distributors & suppliers, and a list of the key market participants in the pancreatic and biliary stent market that are included in the report.

In this chapter, readers can find information about the key Market trends and developments in the pancreatic and biliary stent market and the market associated factors affecting the trends in each region. Readers can find details of market trends, epidemiology, regulatory scenario, and reimbursement. Readers can find detailed information about significant factors, such as the sales trend of pancreatic and biliary stents, which are impacting the growth of the pancreatic and biliary stent market. This chapter also includes a detailed analysis of the proposed growth prospects of the pancreatic and biliary stent market.

Readers can find information about the pricing analysis in the global pancreatic and biliary stent and market attractive analysis. Readers can understand the important qualitative and quantitative pricing information about the pancreatic and biliary stent in the global pancreatic and biliary stent market.

The next chapter includes a detailed analysis of the growth of the pancreatic and biliary stent market, along with a country-wise assessment. Readers can also find information on the global trends in the pancreatic and biliary stent market, along with regulations, company share analysis, and market growth on the basis of product type, application, and end user. Further section contains major indices for the pancreatic and biliary stent market. Some of them include the pancreatic and biliary stent market trends, drivers, opportunities, and restraints.

Based on the product type, the pancreatic and biliary stent market has been segmented into Plastic pancreatic & biliary stent and metal pancreatic & biliary stent. In this chapter, readers can find information about the key trends and developments in the pancreatic and biliary stent market and market attractive analysis based on the product type for each region.

Based on the application, the pancreatic and biliary stent market has been segmented into benign biliary strictures, biliary leaks, malignant obstruction, biliary stones, and pancreatic cancer. In this chapter, readers can find information about the key trends and developments in the pancreatic and biliary stent market and market attractive analysis based on application for each region.

Based on end user, the pancreatic and biliary stent market has been segmented into hospitals, specialty clinics, and ambulatory surgical centers. In this chapter, readers can find information about the key trends and developments in the pancreatic and biliary stent market and the market attractive analysis based on the end user for each region.

The regional analysis explains how the pancreatic and biliary stent market is expected to grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceana, and the Middle East & Africa (MEA).

Next section includes a detailed analysis of the growth of the North America pancreatic and biliary stent market, along with a country-wise assessment of the U.S. and Canada. Readers can also find information on the regional trends in the pancreatic and biliary stent market, along with regulations, company share analysis, and market growth on the basis of product type, application, end user, and country.

Readers can find detailed information about factors such as the pricing analysis of pancreatic and biliary stents and the regional trends that are impacting the growth of the Latin America pancreatic and biliary stent market. This chapter also includes the growth prospects of the pancreatic and biliary stent market in prominent LATAM countries such as Brazil, Mexico, and the Rest of Latin America.

Important growth prospects of the pancreatic and biliary stent market based on product type, application, and end user in several European countries, such as Germany, the UK, France, Italy, Spain, Russia, and the rest of Europe, have been included in this chapter.

Japan and China are among the prominent regions in the East Asia market. Thus, they are the prime subjects of assessment to obtain the growth prospects of the East Asia pancreatic and biliary stent market. In this chapter, readers can find detailed information about the growth parameters of the East Asia pancreatic and biliary stent market for the period 2019–2029.

India, Thailand, Malaysia, Indonesia, Philippines, and the Rest of South Asia are among the prominent regions in the South Asia market. Thus, they are the prime subjects of assessment to obtain the growth prospects of the South Asia pancreatic and biliary stent market. In this chapter, readers can find detailed information about the growth parameters of the South Asia pancreatic and biliary stent market for the period 2019–2029.

Australia and New Zealand are the prominent regions in the Oceana market. Thus, they are the prime subjects of assessment to obtain the growth prospects of the Oceana pancreatic and biliary stent market. In this chapter, readers can find detailed information about the growth parameters of the Oceana pancreatic and biliary stent market for the period 2019–2029.

The following chapter provides information on how the pancreatic and biliary stent market is expected to grow in the major countries of the MEA region, such as GCC Countries and South Africa, during the period 2019–2029. Readers can find important factors that are estimated to have a significant impact on the growth of the pancreatic and biliary stent market in MEA during the forecast period. This chapter also provides an overview of the regulations, drivers, restraints, and trends prevalent in the MEA pancreatic and biliary stent market.

In the competitive landscape, readers can find a comprehensive list of all the leading stakeholders in the pancreatic and biliary stent market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the pancreatic and biliary stent report are Cook Medical Inc., Boston Scientific Corporation, CONMED Corporation, Olympus Corporation, Medtronic Plc., Taewoong Medical Co., Ltd., ENDO-FLEX GmbH., ELLA-CS, s.r.o, Becton, Dickinson and Company, and Abbott Laboratories.

Fragmented market with the presence of few established brands and several local players

The global pancreatic and biliary stents market is fragmented in nature, and is characterized by oligopolistic competition among few renowned brands in the market. Following the patent pool in the pancreatic and biliary stents market, established manufacturers are exploring newer opportunities for revenue generation.

Considering the growth prospects in emerging markets, various companies, such as Cook Medical Inc., Boston Scientific Corporation, CONMED Corporation, and several others, are competing to capture the maximum share in emerging markets. Marketplace discussions related to pancreatic and biliary stents indicate that pancreatic cancer and benign biliary strictures applications exhibit large untapped opportunities for the manufacturers of Pancreatic and Biliary Stents, and this trend is widely observed in the U.S. pancreatic and biliary stents market in ambulatory care centres and cancer care centres.

pancreatic and biliary stents market

Manufacturers in the global pancreatic and biliary stent market are making major investments and are focusing on introducing innovative products to enhance their market shares. For instance, in January 2019, AMG International GmbH received the European CE mark approval for its ARCHIMEDES biodegradable biliary and pancreatic stents. In March 2012, WallFlex Biliary Transhepatic stent system was launched by Boston Scientific Corporation in CE-marked countries for the treatment of benign biliary strictures.

Moreover, some companies, as a part of their strategy to capture a larger market share, are launching pancreatic and biliary stents with additional features. For example, W. L. Gore & Associates, Inc. launched VIABIL Short Wire Biliary Endoprosthesis with a unique antimigration technology that reduces the preoperative procedure. Rapid industrialization in emerging economies in the East African belt, Eastern Europe, and Asia Pacific regions is supporting the production and R&D of low-cost medical devices.

The availability of a well-developed manufacturing infrastructure, low-cost labour, and trained technicians in countries such as China are also among factors supporting the growth of the market. Companies that manufacture pancreatic and biliary stents, such as Taewoong Medical and Boston Scientific, have R&D centres as well as manufacturing divisions based in developing and developed economies such as Ireland, Malaysia, and China. Not only is this strategy profitable, but also results in an increase in the sales of pancreatic and biliary stents in these high-growth markets.

Greater attention toward gastrointestinal surgeries

Advancements in gastrointestinal surgeries during the past few decades have increased the number of the options for the treatment of pancreatic and biliary diseases. The risks associated with gastrointestinal treatment are lower as compared to traditional open surgical treatments. Surgery was the primary treatment for biliary obstruction prior to the use of stents. The use of pancreatic and biliary stents are the mainstay for pancreas divisum therapy, along with new technologies such as stents, which has increased the options for the treatment of complex lesions via open surgery.

The constant development of new innovations and intervention techniques for the treatment of pancreatic diseases is estimated to increase the number of pancreatic and biliary surgeries. These factors are leading to an increase in the number of hospitals floating tenders for the procurement of better-quality pancreatic and biliary stents. This trend is being observed in developed and developing markets in North America, Asia Pacific, and Europe. Thus, growing awareness regarding stent-based treatments is expected to fuel the growth of the pancreatic and biliary stents market during the forecast period.

Complications with pancreatic and biliary metal stents and reported errors

In some cases, the usage of biliary or pancreatic stents in the treatment of biliary disorders and pancreatic cancer leads to various complications and can cause potential blockage. Both these types of stents can cause blockages or adverse effects such as aching muscles, high temperature, tummy pain, and other symptoms. There is also the risk of getting a hole in the duodenum during or after the procedure of stent placement in the duct, which is likely to cause bleeding and infection.

Some of the potential complications associated with the usage of a biliary metal stent placement/ERCP procedure are pain, bleeding, fever, nausea, vomiting, and acute cholangitis associated with CBD stones. Moreover, some of the major complications associated with pancreatic and biliary stents are stent displacement or misplacement, perforation, obstruction, collapse, stent fracture, and certain infections. Such complications are likely to hamper the demand for pancreatic and biliary stents throughout the forecast period.

Market Definition

Pancreatic and biliary stents are used to facilitate the drainage of bile into the digestive tract, mostly in biliary obstruction, biliary fistulas, and biliary strictures. Basically, biliary stents are the currently available endoscopic solutions for stent insertion. The placement of a pancreatic and biliary stent is nearly a new and frequently adopted method to reduce the risk of post-endoscopic retrograde cholangiopancreatography.

About the Report

PMR conducted a research study on the pancreatic and biliary stents market for the forecast period 2019 to 2029. The report offers a comprehensive evaluation of the business opportunities prevailing in the pancreatic and biliary stents market, along with insights on the pancreatic and biliary stents market value analysis based on the region, global & regional market trends, pricing analysis based on product type, regulatory scenario, macro-economic factors, industry insights, pricing analysis by vendors, new disease indication forecast analysis, hazard analysis, and volume analysis by vendors. The Pancreatic and biliary stents market report elaborates the macro-economic factors influencing the dynamics of the market and its futuristic potential.

Pancreatic and biliary stents market: Segmentation

The report on the pancreatic and biliary stents market offers a comprehensive taxonomy of the market for Pancreatic and Biliary Stents based on product type, application, end user, and region.

By product type, the pancreatic and biliary stents market is segmented into plastic pancreatic and biliary stent and metal pancreatic and biliary stent. Metal pancreatic and biliary stent is further subdivided into metal non-covered pancreatic and biliary stents, metal partially covered pancreatic and biliary stents, and metal fully covered pancreatic and biliary stents.

By application, the pancreatic and biliary stents market is segmented into benign biliary strictures, biliary leaks, malignant obstruction, biliary stones, and pancreatic cancer.

By end user, the pancreatic and biliary stents market is segmented into hospitals, ambulatory surgical centers, and specialty clinics.

By region, the Pancreatic and Biliary Stents market is segment into North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

Additional questions answered

Some of the additional questions addressed in this report on the pancreatic and biliary stents market are:

  • What is the revenue potential of the pancreatic and biliary stents market across the regions of North America and Europe?
  • Who are the key competitors and what are their portfolios in the pancreatic and biliary stents market?
  • What are the major challenges influencing the growth of the pancreatic and biliary stents market?
  • How is the intervention of regulatory authorities shaping the growth of the pancreatic and biliary stents market?

Company Profiles

  • Cook Medical Inc. 
  • Boston Scientific Corporation
  • CONMED Corporation 
  • Olympus Corporation
  • Medtronic Plc. 
  • Taewoong Medical Co., Ltd. 
  • ENDO-FLEX GmbH. 
  • ELLA-CS, s.r.o
  • Becton, Dickinson and Company 
  • Abbott Laboratories

 

Back To Top